Violin Jonathan
Insider CIK 1730615 · CBIO Director · TRVN SVP-Scientific Affairs & IR · CATB Director · MGEN See Remarks, Director · DNTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CBIO CRESCENT BIOPHARMA, INC. | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,166 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer | 2026-01-23 | 2026-01-23 | 263,321 | — | $0 | 0 | SEC↗ |
| CBIO GLYCOMIMETICS INC | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2023-02-02 | 2023-02-07 | 50,000 | — | $0 | 239,205 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-02-02 | 2023-02-03 | 50,000 | $36.80 | $1.84M | 430,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2023-02-02 | 2023-02-07 | 50,000 | $0.15 | $7.5K | 530,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2023-02-02 | 2023-02-07 | 50,000 | $36.80 | $1.84M | 480,905 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-06-01 | 2022-06-02 | 30,000 | $12.20 | $366.0K | 480,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-05-02 | 2022-05-04 | 30,000 | $13.04 | $391.2K | 510,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-04-04 | 2022-04-05 | 3,600 | $18.93 | $68.1K | 540,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-04-01 | 2022-04-05 | 26,400 | $18.92 | $499.5K | 544,505 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-03-02 | 2022-03-03 | 11,106 | $17.36 | $192.8K | 570,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-03-01 | 2022-03-03 | 18,894 | $17.82 | $336.7K | 582,011 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-02-03 | 2022-02-03 | 909 | $19.16 | $17.4K | 600,905 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2022-02-02 | 2022-02-03 | 280,000 | — | $0 | 280,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-02-02 | 2022-02-03 | 12,340 | $18.47 | $227.9K | 601,814 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2022-02-01 | 2022-02-03 | 16,751 | $19.55 | $327.5K | 614,154 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | C Conversion deriv | 2021-12-08 | 2021-12-10 | 9,413 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | C Conversion | 2021-12-08 | 2021-12-10 | 627,564 | — | $0 | 630,905 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | J Other | 2021-09-20 | 2021-09-22 | 263,321 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | J Other | 2021-09-20 | 2021-09-22 | 263,321 | — | $0 | 263,321 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-01-28 | 2021-02-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2021-01-18 | 2021-01-20 | 800,075 | — | $0 | 800,075 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other deriv | 2020-10-27 | 2020-10-30 | 4,338,079 | — | $0 | 4,338,079 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other deriv | 2020-10-27 | 2020-10-30 | 9,413 | — | $0 | 9,413 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | J Other | 2020-10-27 | 2020-10-30 | 50,124 | — | $0 | 50,124 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-02-28 | 2018-03-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-02-28 | 2018-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |